Casein kinase 2 (CK2) was one of the first protein kinases to be discovered and has been suggested to be responsible for as much as one-fifth of the eukaryotic phosphoproteome. Despite being responsible for the phosphorylation of a vast array of proteins central to numerous dynamic cellular processes, the activity of CK2 appears to be unregulated. In the current study, we identified a protein kinase activity in rat liver supernatant that is up-regulated by inositol 1,3,4,5-tetrakisphosphate (IP 4 ) and inositol hexakisphosphate (IP 6 ). The substrate for the inositol phosphate-regulated protein kinase was identified as a phosphatidylcholine transfer protein-like protein. Using the phosphorylation of this substrate in an assay, we purified the inositol phosphate-regulated protein kinase and determined it to be CK2. Bacterially expressed recombinant CK2, however, showed very high basal activity and was only modestly activated by IP 6 and not regulated by IP 4 . We found that an endogenous component present in rat liver supernatant was able to inhibit both recombinant and liverpurified CK2 basal activity. Under these conditions, recombinant CK2 catalytic activity could be increased substantially by IP 4 , inositol 1,3,4,5,6-pentakisphosphate (IP 5 ), and IP 6 . We concluded that, contrary to the previously held view, CK2 can exist in a state of low constitutive activity allowing for its regulation by inositol phosphates. The ability of the higher inositol phosphates to directly stimulate CK2 catalytic activity provides the first evidence that these signaling molecules can operate via a direct control of protein phosphorylation.
ger molecule (1) . However, IP 3 is only one of a vast array (numbering potentially as high as 60) of inositol phosphate isomers found within cells (2) . In contrast to IP 3 , the biological function of the majority of these inositol phosphates is either unknown or poorly understood. Of particular interest is the phosphorylated product of IP 3 , namely inositol 1,3,4,5-tetrakisphosphate (IP 4 ), which shows many of the hallmarks of a second messenger molecule. Early studies focused on a role for IP 4 in calcium mobilization; however, the cloning of GAP1 IP4BP , which shows high affinity binding to IP 4 (3) , and the recent demonstration that IP 4 is involved in chromatin remodeling in yeast (4, 5) suggest that IP 4 function may extend beyond calcium signaling.
Of the higher inositol phosphates, possibly the most enigmatic is inositol hexakisphosphate (IP 6 ). Found in all mammalian cells in micromolar concentrations (6, 7) , the biological function of this molecule has remained elusive. An involvement in endo-and/or exocytosis (8, 9) has been indicated by the discovery that a number of proteins involved in this process have a high affinity for IP 6 (10 -12) and that microinjection of IP 6 can regulate synaptic vesicle fusion (13) . Recently, the potential biological processes that may be regulated by IP 6 have been extended by the demonstration that mRNA export (14) , DNA repair (15, 16) , chromatin remodeling (4, 5) , and protein phosphatase activity (17) can all be influenced by IP 6 .
In an attempt to address the question of novel signaling properties of the inositol phosphates, we tested the possibility that protein kinases may exist that are regulated directly by inositol phosphates. The rationale was that, of the established second messenger molecules (e.g. cAMP, cGMP, diacylglycerol, and calcium), the inositol phosphates are unique in that they do not appear to directly activate a protein kinase. In our initial studies, we partially purified a protein kinase from porcine brain that was able to phosphorylate the synaptic vesicle-associated protein pacsin/syndapin I in an IP 6 -dependent manner (18) . This was the first demonstration of an inositol phosphateregulated phosphorylation and supported a role for IP 6 in the control of synaptic vesicle endocytosis. Importantly, the kinase that was identified in porcine brain was only activated by IP 6 and isomers of IP 7 . No activated phosphorylation was observed using the lower inositol phosphates, in particular IP 3 or IP 4 (18) .
In the current study, we have continued with our investigation of inositol phosphate-regulated protein phosphorylation. We report here that phosphatidylcholine transfer protein (PCTP)-like protein, purified from a rat liver supernatant preparation, is a substrate for a protein kinase that is regulated by IP 4 , IP 5 , and IP 6 . Purification of the inositol phosphate-regulated protein kinase revealed the identity of the kinase to be the ubiquitously expressed serine/threonine kinase casein kinase 2 (CK2). Our data demonstrate that CK2, far from being constitutively active as previously thought, is in fact under tight inhibitory control and that, under these conditions, inositol phosphates are able to activate CK2 catalytic activity. Following a 20-min incubation at 37°C, the reaction was terminated by the addition of (2ϫ) Laemmli sample buffer. Phosphorylated proteins were separated on a 12% SDS-polyacrylamide gel, which was then dried and exposed for autoradiography.
EXPERIMENTAL PROCEDURES

Materials-All
Where recombinant CK2 was used, 1.25 units of kinase were mixed with ␣-casein (10 g/assay) and 2.5 l of heat-inactivated Resource S fraction 4 (or corresponding TE buffer containing 2.5 mM Tris, 2.5 mM EDTA, pH 7.4, in controls) and incubated in reaction buffer containing 1 M [ 32 P]ATP (1-10 cpm/fmol ATP) in the presence or absence of inositol phosphates (25 M) . Following 20 min of incubation at 37°C (within a linear range of phosphorylation reaction), the reaction was stopped and processed as described above.
To make a heat-inactivated preparation, 200-l aliquots of Resource S fraction 4 were heated for 5 min at 60°C, cooled on ice, and centrifuged for 3 min at 14,000 ϫ g to separate denatured proteins. Aliquots of the supernatant fraction were used in CK2 assays.
Fractionation of High Speed Liver Supernatant on Resource S (Cation-exchange) Column-Two rat livers (28 -32 g) were homogenized in 150 ml of TE buffer supplemented with 1 mM DTT and 1 mM phenylmethylsulfonyl fluoride. The homogenate was centrifuged at 37,000 ϫ g for 20 min, and the supernatant was further centrifuged at 360,000 ϫ g for 60 min. The supernatant (20 ml) was applied to a 6-ml Resource S (Amersham Biosciences) cation-exchange column and washed with 3 column volumes of TE buffer containing 1 mM DTT. The column was eluted with a linear gradient of 0 -1 M NaCl at a flow rate of 3 ml/min in a total volume of 24 ml. Fractions (3-ml) were collected and assayed for kinase activity. The majority of inositol phosphate-regulated protein kinase activity eluted at 0.25-0.5 M NaCl (i.e. fractions 3 and 4).
Fractionation on Heparin-Sepharose-Fractions 3 and 4 from the Resource S chromatography (containing inositol phosphate-regulated protein kinase activity) were combined and 5 ml applied to a heparinSepharose column (5-ml) (Amersham Biosciences). The column was washed with 2 column volumes of TE buffer containing 1 mM DTT and eluted with a linear gradient of 0 -2 M NaCl in 10 column volumes. Fractions (2.5-ml) were collected and assayed for kinase activity. During this fractionation procedure, the inositol phosphate kinase activity was lost when individual fractions were assayed (see "Results"). To reconstitute kinase activity, the fractions were combined (2.5 l of each fraction) and then used in the kinase reaction. In this way, it was determined that the inositol phosphate-regulated protein kinase was eluted with 0.9 -1.1 M NaCl (fractions 10 and 11), and the ϳ33-kDa substrate protein was eluted with 0.7-0.9 M NaCl (fractions 8 and 9).
Fractionation on Hydroxyapatite-The fractionation procedures described above using Resource S and heparin-Sepharose were repeated 6 times and the kinase fractions combined (total volume, 30 ml) and dialyzed against 5 mM Tris, 5 mM KH 2 PO 4 , pH 7.35, containing 1 mM DTT and 0.1 mM phenylmethylsulfonyl fluoride. Similarly, the substrate fractions were combined and dialyzed against the same buffer. The kinase sample (30-ml) was loaded onto an hydroxyapatite column (1-ml) (Bio-Rad), and the column was washed with 5 The substrate sample (30-ml) was also fractionated on a 1-ml hydroxyapatite column using the same conditions. In this case, the substrate protein was eluted by 0.35-0.45 M KH 2 PO 4 .
Fractionation on Mini-Q Anion-exchange Column (SMART System)-Fractions eluted from the hydroxyapatite column and containing the inositol phosphate-regulated protein kinase activity (fractions 4 -6, total volume 3 ml) were diluted into 10 ml of TE buffer supplemented with 1 mM DTT and applied to a mini-Q column (0.2-ml) (Amersham Biosciences). The column was washed with the same buffer (2 column volumes) and eluted first with a linear gradient of 0 -0.3 M NaCl (5 column volumes) and further with 0.3-0.6 M NaCl (10 column volumes) in TE buffer containing 1 mM DTT. Fractions (200-l) were collected and assayed for kinase activity. The inositol phosphate-regulated protein kinase activity was eluted from the column with 0.36 -0.42 M NaCl (fractions 8 and 9).
It should be noted that the inositol phosphate-regulated activity was labile, and to maintain the kinase with a low basal activity and thus in a state able to be regulated by inositol phosphates, the purification had to be carried out over a short period of 2 days.
Mass Spectrometry-Gel plugs (0.8 mm ϫ 1 mm) excised from Coomassie Blue-stained SDS-polyacrylamide gels, using an automated spot picker (ProPic, PerkinElmer Life Sciences, Cambridge, UK), were reduced with 10 mM DTT and alkylated with 100 mM iodoacetamide before in situ tryptic digestion with Promega modified sequencinggrade porcine trypsin using an automated digestion robot (ProGest, PerkinElmer Life Sciences). Peptides, extracted from the digested gel plugs with 21 l of 0.1% formic acid, were analyzed by either MALDI-TOF and/or LC-MS/MS. For MALDI-TOF, 5-l aliquots of the extracted peptides were desalted with C18 Zip tips (Millipore, Watford, UK), and 0.5-l aliquots and an equal volume of a saturated solution of ␣-cyano-4-hydroxycinammic acid in 1% trifluoroacetic acid and 50% acetonitrile were loaded on to a MALDI target plate using an automated spotting robot (ProMS, PerkinElmer Life Sciences). Peptide mass analysis was then performed on a MALDI-TOF mass spectrometer (M@LDI R, Micromass, Manchester, UK) using a mass range of 900 -3000 Da. Mass spectrometric data were analyzed automatically by ProteinLynx software, and protein identity was determined by submission to the SwissProt and TrEMBL data bases.
The extracted peptides (5 l) were also analyzed by on-line capillary LC-nanospray MS/MS using a 3-m 100 Å Pepmap C18 75 m ϫ 150 mm capillary column (Dionex UK Ltd., Camberly, UK) and a Waters CapLC system. The samples were auto-injected onto a precolumn (5-m, 100-Å Pepmap C18, 300 m ϫ 5 mm) and washed with 0.1% formic acid (30 l/min for 3 min). The peptides were back-flushed onto the analytical column and eluted with a linear gradient (5-40% at 1%/min) of acetonitrile in 0.1% formic acid. The gradient was generated at a flow rate of 6 l/min and then split to allow elution of the column at 200 nl/min into the nanospray source of a Micromass Q-TOF2 mass spectrometer in ϩve. MassLynx TM data-directed scan switching was used to select multiply charged peptide ions for MS/MS analysis using collisioninduced dissociation. The fragment ion spectra were analyzed automatically by ProteinLynx Global Explorer TM , and protein identity was determined by submission to the Swiss-Prot and TrEMBL data bases. Alternatively, spectra were manually sequenced de novo and submitted for an NCBI BLAST search using the nonredundant protein data base.
Synthesis of IP 4 -D-Ins(1,3,4,5)P 4 were synthesized as described by Riley et al. (19) . The structure was confirmed by standard spectroscopic methods (NMR and MS) and was confirmed as being homogenous.
Cloning and Phosphorylation of Bacterially Expressed Phosphatidylcholine Transfer PCTP-like Protein-Mouse (C57/BL/6J) liver total RNA was isolated using TRI-reagent (Sigma). The RNA (400 g) was reverse-transcribed using SuperScript III enzyme (Invitrogen). The resulting cDNA was used in conjugation with primers corresponding to the C-and N-terminal coding sequences of mouse PCTP-like protein (forward primer, 5Ј-GGGGGATCCGCCACCATGGAAAAGCCAGCTG-CCTCAAC-3Ј; reverse primer, 5Ј-GGGGAATTCTCAGGTGAGCGAGG-TGTCATC-3Ј) to amplify the PCTP-like protein coding region with BamHI and EcoRI sites at the N and C termini, respectively. PCTP-like protein was then cloned into pGEX-2T at the BamHI/EcoRI sites to produce a bacterial fusion protein where glutathione S-transferase (GST) was fused to the N terminus of the full-length PCTP-like protein.
GST-PCTP-like protein attached to glutathione-agarose beads (1.65 mg/ml) was used in kinase reactions consisting of 20 l of packed beads in kinase reaction buffer containing 1 M [ 32 P]ATP (1-10 cpm/fmol ATP) and recombinant CK2 (6 units/reaction) in a final reaction volume of 45 l. The reaction was allowed to proceed for 20 min and was stopped by the addition of Laemmli buffer. Proteins were then resolved by 12% SDS-PAGE. The gels were stained with Coomassie Blue to visualize the fusion proteins before exposure to obtain an autoradiograph.
Miscellaneous Procedures-Silver staining was performed using a Bio-Rad Silver Stain Plus kit. Western blotting with the anti-CK2 ␣-subunit antibody was carried out using standard procedures. Protein assays were conducted using the Bradford protein assay reagents (Sigma). Statistics were derived using the Student's paired t test.
RESULTS
Identification of Inositol
Phosphate-mediated Phosphorylation-A high speed supernatant preparation from rat liver was fractionated over a Resource S cation-exchange column, and each fraction was tested in a protein kinase assay for the presence of inositol phosphate-regulated protein phosphorylation (see "Experimental Procedures"). For the majority of phosphoproteins, the presence of inositol phosphates in the assay did not affect the extent of phosphorylation (Fig. 1) . However, in fractions 2-4, an ϳ33-kDa phosphoprotein exhibited a higher level of phosphorylation in the presence of IP 6 (Fig. 1A) and IP 4 (data not shown). Further analysis revealed that phosphorylation of the 33-kDa protein was specificity-increased by IP 4 , IP 5 , and IP 6 but not the lower inositol phosphates (Fig. 1B) . Importantly, in control experiments, inositol hexasulfate (IS 6 ) did not increase phosphorylation of the 33-kDa protein (Fig. 1B) .
Separation of the Inositol Phosphate-regulated Kinase from Its 33-kDa Substrate-Resource S fractions containing the inositol phosphate-regulated phosphorylation were pooled and further fractionated on a heparin-Sepharose column. Testing each fraction in a kinase assay with IP 6 revealed no detectable phosphorylation, except for a very weak signal in fraction 9 (Fig. 2) . It was concluded that this chromatographic step had separated the kinase and substrate, which were now present in distinct fractions. This was tested by mixing fractions in an attempt to reconstitute the phosphorylation activity. It was found that, by mixing fraction 9 with fraction 11, the inositol phosphate-regulated phosphorylation of the 33-kDa protein was restored (Fig. 2) . Similar data were obtained when mixing fraction 8 and fraction 11 (data not shown).
It was concluded that the inositol phosphate-regulated kinase and the substrate protein were contained in fractions 8 -9 and fraction 11. To determine which fractions contained the kinase and which contained the substrate, each fraction was heat-inactivated at 60°C for 5 min. This procedure was designed to inactivate the kinase activity. Heat inactivation of fraction 8 did not affect the kinase reaction when mixed with fraction 11. However, heat inactivation of fraction 11 completely prevented phosphorylation of the 33-kDa protein when mixed with fraction 8 (data not shown). Similarly, heat inactivation of fraction 9 did not affect the kinase reaction when mixed with fraction 11, but heat inactivation of fraction 11 completely prevented phosphorylation (data not shown). It was concluded from these studies that fractions 8 and 9 from the heparin-Sepharose column contained the substrate for an inositol phosphate-regulated kinase that was present in fraction 11. Purification and Identification of the Substrate Protein for the Inositol Phosphate-regulated Kinase-Fractions 8 and 9 from the heparin-Sepharose chromatography were pooled and further fractionated on a hydroxyapatite column. The presence of the substrate protein in the eluate was determined in kinase reactions where the inositol phosphate-regulated kinase was added (see previous paragraph). Phosphorylation of the 33-kDa protein peaked in fractions 8 and 9 from the hydroxyapatite column (Fig. 3A) . This corresponded to the elution of a protein band at 33 kDa that aligned exactly with the phosphorylated band in the kinase reactions (Fig. 3B) . MALDI-TOF analysis of tryptic peptide fragments of the 33-kDa protein resulted in 10 peptides covering 46% of the amino acid sequence, which matched exactly the PCTP-like protein (Fig. 3C) . Further confirmation of the identity of the protein substrate was obtained from sequence analysis by LC-MS/MS of six peptides (Fig. 3C,  underlined) .
Purification and Identification of the Inositol Phosphate-regulated Kinase-Fraction 11 from the heparin-Sepharose column, which was shown to contain kinase activity (see Fig. 2 ), was further fractionated on a hydroxyapatite column. Each fraction was then assayed for inositol phosphate-regulated kinase activity using purified PCTP-like protein as a substrate. The inositol phosphate-regulated kinase activity peaked in fractions 4 -6 (data not shown). These fractions were pooled and further fractionated on a mini-Q anion exchange column. The inositol phosphate-regulated kinase activity eluted from this column in fractions 8 and 9 (Fig. 4A) . The elution of this kinase activity corresponded exactly with the elution of three protein bands at ϳ37, 35, and 25 kDa (Fig. 4B) . MALDI-TOF analysis of tryptic peptides of the 25-kDa band produced 10 peptides corresponding to 47% of the amino acid sequence that matched exactly with the ␤-subunit of CK2 (Fig. 4C) . This identity was confirmed by LC-MS/MS sequencing of 2 peptides (Fig. 4C, underlined) . Similar analysis of 35-kDa bands identified these protein bands as containing a mixture of ␣-and ␣Ј-subunits of CK2. The presence of both ␣-and ␣Ј-subunits was confirmed by LC-MS/MS sequencing for three tryptic peptides (data not shown) and further determined by Western blotting using an antiserum against the ␣-subunit of CK2 (Fig. 4D) .
The phosphorylation of PCTP-like protein by CK2 was further confirmed in studies using recombinant PCTP-like protein expressed as a GST fusion protein in kinase reactions with bacterially expressed recombinant CK2 (Fig. 4E) . In these experiments, GST was not detectably phosphorylated by recombinant CK2. In contrast, GST-PCTP-like protein was phosphorylated by CK2 in a manner that was sensitive to the presence of IP 6 (Fig. 4E) .
Determination of the Presence of an Inhibitory
Regulator of CK2-From the above studies, we would predict that the activity of recombinant bacterially expressed CK2 heterotetramer (rCK2) would be sensitive to inositol phosphates. However, using either PCTP-like protein or ␣-casein as a substrate, it was found that rCK2 activity was increased only modestly by IP 6 (20 -60%) and not at all by IP 4 (Fig. 5A ). In these experiments, rCK2 constitutive activity was very high, a characteristic normally associated with this enzyme. In contrast, the constitutive activity of endogenous CK2 present in the rat supernatant fractions (particularly in the first Resource S fractions) appears low. This conclusion is based on the fact that PCTP-like protein phosphorylation in these fractions is almost undetectable in the absence of inositol phosphates (see Fig. 1 ). These data suggest the presence of a negative regulator of CK2 that is able to diminish CK2 constitutive activity in these rat liver fractions. We reasoned that, under conditions where CK2 constitutive activity was low (because of the presence of the negative regulator), inositol phosphates were able to increase CK2 catalytic activity, possibly by displacing the negative regulator.
To test this possibility, we heat-inactivated fraction 4 from the Resource S column, which appeared to contain CK2 activity in a low basal state (see Fig. 1 ). This procedure removed endogenous protein kinase activity (Fig. 5, B and C) . In the presence of heat-inactivated RS4, it was found that the basal activity of rCK2 was reduced by 83.1% (Fig. 5B) . Under these conditions, the addition of IP 6 was able to increase rCK2 activity by ϳ2.5-fold (Fig. 5B ). These data demonstrate that rCK2 could be regulated in an inositol phosphate-sensitive manner and that this was dependent on low constitutive activity mediated by a heat-insensitive component present in a rat liver supernatant fraction.
It was also noted that, during the purification of liver CK2, the ability of the kinase to be regulated by inositol phosphates was labile (see "Experimental Procedures"). A loss of regulation of the liver-purified CK2 was characterized by an increase in the basal catalytic activity and could be minimized only when the purification process was carried out over a short time period. This suggested that the regulator-CK2 interaction was weak and readily lost during purification. This conclusion was supported by the finding that liver-purified CK2, which had lost the ability to be regulated by inositol phosphates, could be restored to a regulated state by the addition of heat-inactivated RS4 (Fig. 5C ). This restoration correlated with a decrease in the basal activity observed in the presence of heat-inactivated RS4 (Fig. 5C) .
Using rCK2 in the presence of heat-inactivated RS4, we were able to test the ability of various inositol phosphates to stimulate rCK2 activity. It was found that IP 4 , IP 5 , and IP 6 were able to stimulate rCK2 phosphorylation of PCTP-like protein (Fig.  6) and ␣-casein (data not shown), with IP 6 giving the largest response. The lower inositol phosphates (most notably among which is IP 3 ) were unable to stimulate rCK2 activity. Importantly, the control compound IS 6 was also unable to stimulate rCK2 activity (Fig. 6 ). These data are qualitatively similar to the data presented in Fig. 1B and lend further evidence to the fact that CK2 is the inositol phosphate-regulated protein kinase responsible for PCTP-like protein phosphorylation in rat liver supernatant fractions.
DISCUSSION
Despite CK2 being one of the first protein kinases to be discovered nearly 50 years ago (20) , the mechanism by which this ubiquitous kinase is regulated has remained obscure (21, 22 ). In the current study, we have demonstrated the existence of an inositol phosphate-regulated protein kinase in a rat liver supernatant fraction. Purification of this protein kinase identified it as CK2. We found that the ability of CK2 to be regulated by the inositol phosphates is dependent on the kinase being maintained in a state of low basal activity. This is achieved by a putative negative regulator that co-purifies with CK2. In the presence of the negative regulator, CK2 basal activity is low, and under these conditions, inositol phosphates can increase the catalytic activity of the kinase. These studies provide the first evidence for the existence of a signaling mechanism that controls CK2 activity.
CK2 is a highly conserved serine/threonine protein kinase that exists as a heterotetramer of two ␣-and two ␤-subunits. The ␣-subunit is the catalytic subunit and is the product of two different genes encoding ␣ and ␣Ј. The ␤-subunit is noncatalytic and is involved in substrate recognition and stabilization of the kinase complex. This heterotetramer can exist containing two identical ␣-subunits (i.e. ␣ 2 ␤ 2 or ␣Ј 2 ␤ 2 ) or with nonidentical ␣-subunits (i.e. ␣␣Ј␤ 2 ). The ubiquitous expression of CK2 and its pleiotropic nature has led to the suggestion that one-tenth to one-fifth of the eukaryotic phosphoproteome is the result of CK2-mediated phosphorylation (23) . Many of the substrates for CK2 are involved in key dynamic cellular functions, such as gene transcription/translation, cell cycle regulation, and various aspects of signal transduction (23) . Paradoxically, despite CK2 holding a central position in the phosphorylation and regulation of proteins involved in dynamic cellular events, its own activity appears to be unregulated. The apparent constitutive activity of CK2 has prompted the postulation that changes in the phosphorylation status of CK2 substrates would depend on regulated dephosphorylation (24) .
Our studies originally set out to determine whether a protein kinase existed that might be directly regulated by inositol phosphates. We investigated whether endogenous protein kinases contained in rat liver supernatant could be stimulated by inositol phosphates. In these experiments, we were relying on the putative inositol phosphate-regulated kinase(s) co-purifying over one chromatography step (i.e. the Resource S column) with their substrate proteins. Using this approach, we identified a 33-kDa protein that was increased in its phosphorylation state by IP 4 , IP 5 , and IP 6 . This protein was identified as PCTPlike protein and was subsequently used in an assay to purify the inositol phosphate-regulated kinase. The final step in purification revealed that the elution of CK2 (identified by mass spectrometry and immunoblots) corresponded with the elution of the inositol phosphate-regulated protein kinase activity. Definitive evidence that CK2 catalytic activity could be regulated by inositol phosphates was obtained by using bacterially expressed recombinant rCK2, which was shown to be regulated by inositol phosphates with a profile (i.e. IP 4 Ͻ IP 5 Ͻ IP 6 ) that was the same as that observed for phosphorylation of PCTPlike protein in the early Resource S fractions from rat liver. In control experiments, RS4 inac was incubated in kinase assays in the absence of rCK2. C, liver-purified CK2 (which demonstrated high constitutive activity) was incubated in kinase assays as described in B above. The arrow indicates the position of ␣-casein as determined by Coomassie Blue staining. *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001 (Student's paired t test, n ϭ 4 -6).
One of the most unexpected findings to come from our studies was that CK2, contrary to established opinion, can exist in a state where it has very low constitutive activity. In fractions of liver supernatant derived from the first chromatography step, the phosphorylation of PCTP-like protein is low or often undetectable. Only in the presence of inositol phosphates is phosphorylation of PCTP-like protein observed. This would indicate that in these fractions CK2 has very low constitutive, or basal, activity. We reasoned that this may be due to the presence of an endogenous negative regulator in these fractions that is able to inhibit basal CK2 activity. Only in the presence of the negative regulator are inositol phosphates able to increase the catalytic activity of CK2, possibly by simply "displacing" the negative regulator. This hypothesis was supported by the fact that a heat-inactivated fraction containing the putative negative regulator could be used to decrease the constitutive activity of recombinant rCK2 and, in so doing, impart inositol phosphate sensitivity to rCK2.
The identity of this negative regulator has yet to be fully established. It is clear, however, that it is not one of the subunits of the kinase heterotetramer, because rCK2 (which consists of human ␣␣␤ 2 ) has characteristically high constitutive activity when assayed in the absence of fractions containing the negative regulator. This conclusion is relevant, because there is accumulating evidence pointing to the importance of the noncatalytic ␤-subunit in modulation of kinase activity as well as substrate specificity and CK2 complex formation (25, 26) . The negative regulator does not appear to be a phosphatase, because the kinase assays were carried out in ␤-glycerol phosphate to inhibit phosphatase activity and also heat treatment (which would be expected to inactivate phosphatases) had no effect on the negative regulator. Furthermore, it is not a small regulatory molecule that would easily be lost in dialysis. It is important to note that maintaining liver-derived CK2 with low constitutive activity during purification is difficult, suggesting that the regulator-kinase interaction is labile. This point may provide an explanation for the fact that this phenomenon has not been reported before. Further studies are currently in progress to fully establish the molecular identity of the inhibitory regulator of CK2.
Any regulatory process for CK2 would have to reflect the ubiquitous nature of this protein kinase and be accessible to a multitude of distinct stimuli that would target the numerous responses influenced by CK2 phosphorylation. The involvement of inositol phosphates as a regulator of CK2 would meet many of the criteria expected of a broad range regulator of cellular function. Of particular interest is the fact that IP 4 is able to increase the activity of CK2. This inositol phosphate is the product of inositol 1,4,5-trisphosphate 3-kinase, which phosphorylates IP 3 to IP 4 (2) . The large increase in cellular levels of IP 3 on the activation of phospholipase C-␤, through the stimulation of G-protein coupled receptors, is associated with a sharp increase in the levels of IP 4 (27) (28) (29) . On removal of the stimulus, IP 4 is dephosphorylated by the same inositol phosphatase that dephosphorylates IP 3 , namely inositol polyphosphate 5-phosphatase (30) . Our results demonstrated that IP 4 , but not IP 3 , can regulate the activity of CK2. This suggests that CK2 could be under the regulated control of changes in IP 4 and that this process may offer a potential novel signaling pathway for IP 4 .
Whereas IP 4 represents a potential second messenger mechanism for the regulation of CK2, our study also demonstrated that IP 6 can regulate CK2 activity. In fact, IP 6 appears more effective than IP 4 . In contrast to IP 4 , IP 6 is present in high concentrations (10 -60 M) in all eukaryotic cells (6, 7) , and these levels do not appear to change following cellular stimulation (31) . However, interest in IP 6 as a potential regulatory molecule in specific cellular processes has been recently resurrected by studies demonstrating that IP 6 can bind with high affinity to a number of proteins involved in endo-and/or exocytosis (10 -12) . In addition, other studies have demonstrated a role for IP 6 in the control of gene transcription, mRNA export, and DNA repair (4, 5, 14 -16) . This growing literature has forced a rethink of the cellular significance of IP 6 in a diverse array of cell functions (2). Our finding that IP 6 can regulate CK2 activity adds to this literature and suggests that IP 6 may have a signaling role in the direct control of protein phosphorylation.
In this study we identified PCTP-like protein as a substrate for CK2. However, the cellular function of PCTP-like protein is currently unknown. With only 17% amino acid identity with the rat phosphatidylcholine transfer protein, it is not clear if PCTP-like protein has any activity associated with lipid transfer between intracellular compartments. It will be interesting to test whether phosphatidylcholine transfer protein or other lipid transfer proteins are also substrates for CK2 and whether the phosphorylation of these proteins are regulated by inositol phosphates.
In summary, we provide the first evidence to suggest that CK2, rather than being constitutively active, exists in a state with low basal activity. In this state, the kinase activity can be controlled by inositol phosphates. In this way, CK2-mediated phosphorylation may be regulated by a signaling process akin to second messenger-regulated protein kinase pathways.
